STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Cryoport, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Cryoport, Inc. Schedule 13G filing discloses that Integrated Core Strategies (US) LLC reports beneficial ownership of 2,555,766 shares and Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial ownership of 2,562,717 shares of Cryoport common stock, representing 5.1% of the class for each Millennium-related reporting person. The filing, reflecting an event date of 09/24/2025 and signed 09/25/2025, shows shared voting and dispositive power (no sole voting or dispositive power). The participants submitted a Joint Filing Agreement as Exhibit I.

Positive
  • Disclosed >5% ownership by Millennium-related reporting persons, improving market transparency
  • Joint Filing Agreement executed and included as Exhibit I, clarifying coordinated reporting
Negative
  • None.

Insights

TL;DR Millennium-related entities disclose roughly 5.1% stakes with shared voting and dispositive power; filing signals passive, disclosed ownership.

The Schedule 13G indicates each Millennium-related reporting person holds approximately 5.1% of Cryoport's outstanding common stock with shared voting and dispositive power and no sole control. The filing includes the required certification that the positions were not acquired to influence control and a Joint Filing Agreement among the reporting persons. For investors, this documents a meaningful but non-controlling position and preserves transparency on potential aggregation of holdings across related entities.

TL;DR Reporting persons disclosed coordinated ownership via a joint filing but assert passive intent; governance influence appears limited based on this filing.

The disclosure shows coordinated reporting by Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, supported by a Joint Filing Agreement. Each Millennium-related filer reports shared voting and dispositive power but no sole power, and the certification states the stakes are not held to change or influence control. From a governance perspective, the filing documents potential alignment among related entities while asserting a passive posture under Schedule 13G standards.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:09/25/2025
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:09/25/2025
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:09/25/2025
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:09/25/2025

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of September 25, 2025, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What stake in Cryoport (CYRX) is reported by the Millennium-related filers?

Each Millennium-related reporting person discloses beneficial ownership of 2,562,717 shares (reported as 5.1% of the class). Integrated Core Strategies (US) LLC reports 2,555,766 shares.

Do the filers claim they intend to influence control of Cryoport (CYRX)?

No. The certification in the Schedule 13G states the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

What type of voting and dispositive power do the reporting persons have over CYRX shares?

All reporting persons report 0 sole voting and dispositive power and shared voting and shared dispositive power for the disclosed shares.

When was the event requiring this Schedule 13G filing and when was it signed?

The date of the event requiring the filing is 09/24/2025 and the filing is signed by authorized representatives on 09/25/2025.

Is there an exhibit documenting the relationship among the filers?

Yes. The filing includes Exhibit I, a Joint Filing Agreement dated September 25, 2025, among the reporting persons.
Cryoport Inc

NASDAQ:CYRX

CYRX Rankings

CYRX Latest News

CYRX Latest SEC Filings

CYRX Stock Data

438.60M
47.31M
3.82%
100.71%
5.44%
Integrated Freight & Logistics
Pharmaceutical Preparations
Link
United States
BRENTWOOD